Skip to main content
Start of content

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Minutes of Proceedings

Standing Committee on Health (HESA)
42nd Parliament, 1st Session
Meeting No. 77
Tuesday, November 7, 2017, 3:58 p.m. to 5:28 p.m.
Presiding
Bill Casey, Chair (Liberal)

Expand AllCollapse All
• Mark Gerretsen for Doug Eyolfson (Liberal)
Library of Parliament
• Karin Phillips, Analyst
• Marlisa Tiedemann, Analyst
Antimicrobial Resistance
Canadian Patient Safety Institute
• Sandi Kossey, Senior Director, Strategic Partnerships and Priorities
• Kim Neudorf, Patient, Patients for Patient Safety Canada
Halton Healthcare
• Dr. Neil Rau, Infectious Diseases Specialist and Medical Microbiologist
As an individual
• Yvonne Shevchuk, Associate Dean Academic and Professor, College of Pharmacy and Nutrition, University of Saskatchewan
Pursuant to Standing Order 108(2) and the motions adopted by the Committee on Monday, March 7, 2016, and on Thursday, May 4, 2017, the Committee resumed its study of antimicrobial resistance.

Dr. Neil Rau, Sandi Kossey, Kim Neudorf and Yvonne Shevchuk made statements.

Dr. Neil Rau, Yvonne Shevchuk and Sandi Kossey answered questions.

At 5:10 p.m., Marilyn Gladu took the Chair.

At 5:13 p.m., the sitting was suspended.

At 5:15 p.m., the sitting resumed in camera.

Committee Business
The Committee proceeded to the consideration of matters related to Committee business.

It was agreed, — That, in relation to the study of antimicrobial resistance, two additional witnesses be added to the meeting on international perspectives.

It was agreed, — That the draft letter, as amended, summarizing the most credible evidence and best advice the Committee has received concerning several discreet issues it deems important in relation to Bill C-45 be adopted.

At 5:28 p.m., the Committee adjourned to the call of the Chair.



David Gagnon
Clerk of the Committee